Astera Labs, Inc. Common Stock(ALAB)Earnings, Financials & Key RatiosAstera Labs, Inc. Common Stock (ALAB) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company exhibits impressive 93.4% revenue growth, the current P/E ratio of 321.10 and significant stock-based compensation of $48.9 million suggest that the valuation may already price in aggressive future performance.
Astera Labs, Inc. Common Stock (ALAB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Astera Labs, Inc. Common Stock (ALAB) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.61vs $0.54+13.6% | $308Mvs $292M+5.5% |
| Q1 2026 | Feb 10, 2026 | $0.58vs $0.52+12.4% | $271Mvs $250M+8.4% |
| Q4 2025 | Nov 4, 2025 | $0.49vs $0.39+25.7% | $231Mvs $206M+11.7% |
| Q3 2025 | Aug 5, 2025 | $0.44vs $0.32+35.8% | $192Mvs $172M+11.3% |
Recent stock market news and headlines for Astera Labs, Inc. Common Stock (ALAB)
The chairman of the board of directors sold approximately 137,000 shares at a weighted-average price of $442.01 per share on July 1, 2026. The transaction resulted in about a 10% reduction in the insider's total equity stake in the company.
Prominent AI investor Gavin Baker believes that the current hardware cycle is fundamentally different from past tech bubbles.
Astera Labs Inc (NASDAQ: ALAB) shares are climbing Monday as strength returns to the semiconductor group, with chip stocks bouncing back from a choppy late June on renewed conviction in demand across the sector.
JPMorgan's concentrated small-cap fund outpaced Vanguard over one year, but carries higher volatility and a steeper expense ratio.
Stocks are trading mixed as chip stocks rally, with the Dow pulling back from record highs
Key metrics vs top competitors for Astera Labs, Inc. Common Stock (ALAB)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $382.89 | $65.17B | 313.84 | 115.13% | 25.7% | 18.82% | — | |
| $230.70 | $201.82B | 75.15 | 42.09% | 28.99% | 16.84% | — | |
| $146.57 | $7.48B | 18.70 | 5.34% | 20.75% | 20.21% | — | |
| $304.82 | $23.26B | -417.56 | 32.58% | 16.46% | 13.19% | — | |
| $51.55 | $9.55B | -640.37 | 22.77% | -1.67% | -1.57% | — | |
| $58.15 | $2.7B | -118.67 | -11.11% | -14.69% | -4.89% | — |
Astera Labs, Inc. Common Stock (ALAB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Astera Labs, Inc. Common Stock (ALAB) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
Feb 10, 2026·SEC
Feb 10, 2026·SEC
Get notified when ALAB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Astera Labs, Inc. Common Stock (ALAB) stock FAQ — growth, dividends, profitability & financials explained
Astera Labs, Inc. Common Stock (ALAB) reported $1.00B in revenue for fiscal year 2025. This represents a 1154% increase from $79.9M in 2022.
Astera Labs, Inc. Common Stock (ALAB) grew revenue by 115.1% over the past year. This is strong growth.
Yes, Astera Labs, Inc. Common Stock (ALAB) is profitable, generating $267.6M in net income for fiscal year 2025 (25.7% net margin).
Astera Labs, Inc. Common Stock (ALAB) has a return on equity (ROE) of 18.8%. This is reasonable for most industries.
Astera Labs, Inc. Common Stock (ALAB) generated $342.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
